News & Media Filter All News Article Press Release Page: 1 of 3 Press Release Remix Therapeutics Closes $70 Million Series B Financing > Press Release Remix Therapeutics Announces Publication on Reprogramming RNA Processing > Press Release Remix Therapeutics to Participate in SVB Leerink Biopharma Private Company Connect > Press Release Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing > Press Release Remix Therapeutics to Present at RNA Leaders World Congress > Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com
